Leucine-Rich Alpha-2-Glycoprotein 1 is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Jude P J SavarrajDevin W McBrideEunsu ParkSarah HindsAtzhiry PazAaron GusdonRen XuefangSheng PanHilda AhnstedtGabriela Delevati ColpoEunhee KimZhongming ZhaoLouise McCulloughHuimahn Alex Choi

Published in: Neurocritical care (2022)

Plasma LRG1 is a biomarker for EBI, DCI, and functional outcomes after SAH. Further studies to elucidate the role of LRG1 in the pathophysiology of SAH are needed.

Keyphrases

subarachnoid hemorrhage
brain injury
cerebral ischemia
case control
blood brain barrier